Inhibition of poly (ADP-ribose) Polymerase-1 (PARP-1) improves endothelial function in pulmonary hypertension
| dc.contributor.author | Shafiq Mohammad | |
| dc.contributor.author | Lone Zahid Rasool | |
| dc.contributor.author | Abdulkareem Adam Olaitan | |
| dc.contributor.author | Kaura Gurpreet | |
| dc.contributor.author | Sai Navya | |
| dc.contributor.author | Singh Himalaya | |
| dc.contributor.author | Jagavelu Kumaravelu | |
| dc.contributor.author | Kashif Hanif | |
| dc.date.accessioned | 2025-04-27T12:14:17Z | |
| dc.date.available | 2025-04-27T12:14:17Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Endothelial dysfunction is critical in the pulmonary vasculature during pulmonary hypertension (PH). Moreover, in PH, increased inflammation and oxidative/nitrosative stress cause DNA damage, activating poly (ADP-ribose) polymerase-1 (PARP-1). Meloche et al. (2014) and our previous research have shown that inhibiting PARP-1 is protective in PH and associated RV hypertrophy. However, the role of PARP-1 in pulmonary arterial endothelial dysfunction has not been explored completely. Therefore, the current study aims to investigate the involvement of PARP-1 in endothelial dysfunction associated with PH. Hypoxia (1% O2) was used to induce a PH-like phenotype in human pulmonary artery endothelial cells (HPAECs), and PARP-1 inhibition was achieved via siRNA (60 nM). For the in vivo study, male Sprague Dawley rats were administered monocrotaline (MCT; 60 mg/ kg, SC, once) to induce PH, and 1, 5-isoquinolinediol (ISO; 3 mg/kg) was administered daily intraperitoneally to inhibit PARP-1. PARP-1 inhibition decreased proliferation and inflammation, as well as improved mitochondrial dysfunction in hypoxic HPAECs. Furthermore, PARP-1 inhibition also promoted apoptosis by increasing DNA damage in hypoxic HPAECs. In addition, inhibition of PARP-1 reduced cell migration, VEGF expression, and tubule formation in hypoxic HPAECs. In in vivo studies, PARP-1 inhibition by ISO significantly decreased the RVP and RVH as well as improved endothelial function by increasing the pulmonary vascular reactivity and expression of p-eNOS in MCT-treated rats. | |
| dc.identifier.uri | https://uilspace.unilorin.edu.ng/handle/123456789/15497 | |
| dc.title | Inhibition of poly (ADP-ribose) Polymerase-1 (PARP-1) improves endothelial function in pulmonary hypertension |